Abstract:Background: Post-stroke depression (PSD) is common and associated with higher mortality, poorer recovery, more pronounced cognitive deficits, and lower quality of life than is stroke without depression. This manuscript will conduct an updated, comprehensive and clinically-useful review of the risk factors, pathophysiology, assessment, prevention, and treatment of PSD. Methods: This narrative review summarizes articles obtained on PubMed, Medline, EMBase, Google Scholar and the Cochrane Database. This review prioritized articles with a more robust level of evidence, such as original articles with longitudinal data and/or larger samples, randomized controlled trials, systematic reviews, and metaanalyses. Results: One hundred twenty-four articles were reviewed, of which 44 (35%) were published before 2016 and 80 (65%) that were published since 2016. Discussion: Rates of PSD range from 18 to 33%, yet it is vastly underdiagnosed and undertreated. Risk factors for PSD include female sex, history of psychiatric illness, large or multiple strokes, injuries in frontal/anterior areas or in the basal ganglia, stroke occurrence within the past year, poor social support, and pronounced disability. The pathophysiology of PSD is multifactorial and likely involves decreased levels of monoamines, abnormal neurotrophic response, increased inflammation with dysregulation of hypothalamic-pituitary-adrenal axis, and glutamate-mediated excitotoxicity. The evidence for preventive interventions for PSD is somewhat inconsistent and modest. The best treatment for PSD consists of the combination of pharmacological, psychosocial and stroke-focused interventions. Conclusion: PSD is a common, treatable condition that is associated with several negative outcomes. Early detection and proper management are critical to obtain better outcomes in individuals with PSD.

Advancing Post-Stroke Depression Research: Insights from Murine Models and Behavioral Analyses

Poststroke Depression: A Scientific Statement for Healthcare Professionals from the American Heart Association/American Stroke Association

Neuromodulation Strategies in Post-Traumatic Stress Disorder: From Preclinical Models to Clinical Applications

Pathological Mechanism and Drug Therapy for Post Stroke Depression

Neural Substrates of Poststroke Depression: Current Opinions and Methodology Trends

The Efficacy of Therapies for Post-Stroke Depression in Aging: an Umbrella Review.

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Models of Poststroke Depression and Assessments of Core Depressive Symptoms in Rodents: How to Choose?

Post-stroke depression: A 2020 updated review

Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice

An Updated Review on Prediction and Preventive Treatment of Post-Stroke Depression

Advances in antidepressants for treating post-stroke depression

Poststroke depression: psychopharmacological considerations

Research progress of poststroke depression

Anhedonia and activity deficits in rats: impact of post-stroke depression

Pharmacological and Psychotherapeutic Interventions for Management of Poststroke Depression

Natural Products for the Treatment of Post-stroke Depression

Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes

Establishment and Evaluation of Post-stroke Depression Rat Model

Antidepressant-like Effects of Paeoniflorin on Post-Stroke Depression in a Rat Model.

Exploring the pathogenesis and treatment of PSD from the perspective of gut microbiota